| Trustees | Professor A N Barclay, DPhil |
|---|---|
| Professor J Errington, FRS, FMedSci | |
| Professor Sir John Walker, FRS, FMedSci | |
| Professor Penny Handford, Dphil | |
| ProfessorARGreen, PhD | |
| Professor Anton van der Merwe | |
| Charity number | 309698 |
| Auditor | Critchleys Audit LLP |
| Beaver House | |
| 23-38 Hythe Bridge Street | |
| Oxford | |
| OX12EP | |
| Bankers | CAF BankLtd |
| 25 King Hill Avenue | |
| West Malling | |
| Kent | |
| ME19 4JQ | |
| Solicitors | Knights Solicitors |
| Midland House | |
| West Way | |
| Oxford | |
| OX20PH | |
| Investment advisors | Schroder (Cazenave) Personal Investment Management |
| 1 London Wall Place | |
| London | |
| EC2Y 5AU | |
| OU Endowment Management | |
| 27Park End Street | |
| Oxford | |
| OX11HU | |
| BMO Global Asset Management | |
| 12 Primrose St | |
| Exchange House | |
| London | |
| EC2A2NY |
| Page | |
|---|---|
| Trustees report | 1 - 3 |
| StatementofTrustees responsibilities | 4 |
| Independent auditor's report | 5-8 |
| Statementoffinancial activities | 9 - 10 |
| Balance sheet | 11 |
| Statementofcash flows | 12 |
| Notestothe financial statements | 13-24 |
24/10/2022
| Current financial year | |||||
|---|---|---|---|---|---|
| Unrestricted | Endowment | Total |
Total | ||
| funds | funds | ||||
| 2022 | 2022 | 2022 | 2021 | ||
| Notes | £ | £ | £ | £ |
|
| Income from: | |||||
| Investment Income | 3 | 3,841,435 | 3,841,435 | 3,527,725 | |
| Expenditure on: | |||||
| Investment Management Costs | 4 | 2,149 | - | 2,149 | 1,702 |
| Charitable activities | |||||
| Administrative costs | 5 | 22,401 | - | 22,401 | 16,878 |
| Grants Awarded | 5 | 1,880,504 | 1,880,504 | 861,920 | |
| Total charitable expenditure | 1,902,905 | 1,902,905 | 878,798 | ||
| Total resources expended | 1,905,054 | - | 1,905,054 | 880,500 | |
| Net gains/(losses) on investments | 9 | - | 3,438,038 | 3,438,038 | 20,226,663 |
| Net incoming resources before transfers | 1,936,381 | 3,438,038 | 5,374,419 | 22,873,888 | |
| Gross transfers between funds | (1,325,161) | 1,325,161 |
|||
| Fund balances at 6 April 2021 | 1,327,949 | 98,759,051 | 100,087,000 | 77,213,112 | |
| Fund balancesat5 April 2022 | 1,939,169 | 103,522,250 | 105,461,419 | 100,087,000 |
| Prior financial year | ||||
|---|---|---|---|---|
| Unrestricted | Endowment | Total | ||
| funds | funds | |||
| 2021 | 2021 | 2021 | ||
| Notes | £ | £ | £ | |
| Income from: | ||||
| Investment Income | 3 | 3,527,725 | 3,527,725 | |
| - | ||||
| Expenditure on: | ||||
| Investment Management Costs | 4 | 1,702 | 1,702 | |
| Charitable activities | ||||
| Administrative costs | 5 | 16,878 | 16,878 | |
| Grants Awarded | 5 | 861,920 | 861,920 | |
| Total charitable expenditure | 878,798 | 878,798 | ||
| Total resources expended | 880,500 | 880,500 | ||
| Net gains/(losses)oninvestments | 9 | - | 20,226,663 | 20,226,663 |
| Net incoming resources before transfers | 2,647,225 | 20,226,663 | 22,873,888 | |
| Gross transfers between funds | {3,142,841) | 3,142,841 |
||
| Net movementinfunds | (495,616) | 23,369,504 | 22,873,888 | |
| Fund balances at 6 April 2020 | 1,823,565 | 75,389,547 | 77,213,112 | |
| Fund balancesat5 April 2021 | 1,327,949 | 98,759,051 | 100,087,000 |
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ |
£ | £ |
|
| Fixed assets | |||||
| Investments | 10 | 103,522,250 | 98,759,051 | ||
| Current assets | |||||
| Debtors | 12 | 387,856 | 373,590 | ||
| Cash at bank and in hand | 4,605,701 | 3,653,354 | |||
| 4,993,557 | 4,026,944 | ||||
| Creditors: amounts falling due within | |||||
| one year | 13 | (2,723,021) | (1,930,329) | ||
| Net current assets | 2,270,536 | 2,,096,615 | |||
| Total assets less current liabilities | 105,792,786 | 100,,855,666 | |||
| Creditors: amounts falling due after | |||||
| more than one year | 14 | (331,367) | (768,666) | ||
| Net assets | 105,461,419 | 100,,087,000 | |||
| Capital funds | |||||
| General endownment funds | 16 | 103,522,250 | 98,759,051 | ||
| Income funds | |||||
| Unrestricted funds | 1,939,169 | 1,327,949 | |||
| 105,461,419 | 100,,087,000 |
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ |
£ | £ | |
| Cash flows from operating activities | |||||
| Cash absorbed by operations | 19 | (1,563,927) | (917,810) | ||
| Investing activities | |||||
| Purchase of investments | (2,000,000) | (100,000) | |||
| Proceedsondisposalofinvestments | 674,839 | 261,694 | |||
| Investment income received | 3,841,435 | 3,527,725 | |||
| -- | |||||
| Net cash generated from investing | |||||
| activities | 2,516,274 | 3,689,419 | |||
| Net cash used in financing activities | |||||
| Net increaseincash and cash equivalents | 952,347 | 2,771,609 | |||
| Cash and cash equivalents at beginningofyear | 3,653,354 | 881,745 | |||
| Cash and cash equivalentsatendofyear | 4,605,701 | 3,653,354 |
| Unrestricted | Unrestricted | |
|---|---|---|
| funds | funds | |
| 2022 | 2021 | |
| £ | £ | |
| Interest received | 5 | 296 |
| Dividends and interest | 3,841,430 | 3,527,429 |
| 3,841,435 | 3,527,725 | |
| -- |
| Unrestricted | Unrestricted | |
|---|---|---|
| funds | funds | |
| 2022 | 2021 | |
| £ | £ | |
| Portfolio management | 2,149 | 1,702 |
| 2,149 | 1,702 |
| Grants | Grants | |
|---|---|---|
| Awarded | Awarded | |
| 2022 | 2021 | |
| £ | £ | |
| Grants to institutions | 1,880,504 | 861,920 |
| 1,880,504 | 861,920 | |
| 2022 | 2021 | |
| £ | £ | |
| DepartmentofBiochemistry - Specific RNAs | 69,763 | |
| DepartmentofChemistry - Inorganic - Developing Biocatalysis | 72,774 | |
| OUMNH a - Project IMAGOS | 126,979 | |
| DepartmentofBiochemistry - Expanding Access | 28,160 | |
| DepartmentofBiochemistry - Histone in genome stability | 32,558 | |
| DepartmentofBiochemistry - Cryo-EM structure determination | 50,184 | |
| DepartmentofBiochemistry - Purchase protein crystal imaging system | 69,194 | |
| DCHI** - Focused ion beam and scanning electron microscope | 366,495 | |
| DPAG - Support for year twoofa postdoc | 39,906 | |
| DepartmentofBiochemistry - Defining the roleofPARPs in the DNA | 32,252 | |
| DepartmentofPharmacology - Equipment request | 11,238 | |
| KIR - Establishing Advanced Image Analysis | 79,768 | |
| OBGA *** - Plant records management | 61,561 | |
| DepartmentofBiochemistry - Support for outreach events | 7,360 | |
| DepartmentofBiochemistry-Anultracentrifuge for Biochemistry | 40,000 | |
| Royal Society - Human Genome Editing | 140,000 | |
| DepartmentofBiochemistry - Support screening microscope | 80,000 | |
| DPAG13-Advanced 3D Parkinson's stem cell disease models | 143,697 | |
| DepartmentofBiochemistry - Phosphorylation sites | 30,672 | |
| DepartmentofBiochemistry - Regulationofnon-coding RNAs | 47,644 | |
| MSDO* - Bridging salary scheme | 250,000 |
| 6 | Grants payable | (Continued) | |
|---|---|---|---|
| HistoryofScience Museum - Collecting COVID | 251,989 | ||
| EM Facility - Research assistant to support projects | 152,260 | ||
| DepartmentofBiochemistry - Target search mechanisms | 5,890 | ||
| DepartmentofBiochemistry - Modelling toolkit for glycans | 45,076 | ||
| DepartmentofBiochemistry - Genotoxic stress on epimutations | 93,474 | ||
| DepartmentofBiochemistry - Site-specific ADP-ribosylation | 26,522 | ||
| OUMNH a - Next generationofEPA Internships | 112,969 | ||
| DepartmentofBiochemistry - New suiteofelectron microscopes | 500,000 | ||
| 2,068,882 | 899,503 | ||
| KIR Kennedy InstituteofRheumathology | |||
| *Medical Sciences Division Oxford | |||
| ** Dorothy Crowfoot Hodgkin Institute | |||
| *** Oxford Botanic Garden & Arboretum | |||
| #DepartmentofPlant Sciences | |||
| a Oxford University MuseumofNatural History | |||
| ~DepartmentofPhysiology, Anatomy and Genetics | |||
| WIMM Weatherall InstituteofMolecular Medicine |
| Adjustments to grants duringtheyearwereasfollows: | 2022 | 2021 |
|---|---|---|
| £ | £ | |
| DepartmentofBiochemistry - Expanding user access to NMR - (30,306) | (30,306) | |
| DepartmentofZoology - Support - (7, 168) | (7,168) | |
| DepartmentofBiochemistry - Post doctoral support(x2)- (109) | (109) | |
| DepartmentofBiochemistry - Nanobodies etc. facility (10) - | (10) | |
| OUMNH a - Summer internship programme (26,556) - | (26,556) | |
| Linacre College - Widening participation scholarships (1,052) - | (1,052) | |
| Chemistry - Inorganic - Energized NanoconfinementofEnzymes (2,808) - | (2,808) | |
| DepartmentofBiochemistry - Histone ADP-ribosylation (1) - | (1) | |
| DepartmentofBiochemistry - Cryo-EM structure determination (13,926) - | (13,926) | |
| DepartmentofBiochemistry - Defining the role PARPsinDNA Repair (327) - | (327) | |
| DPAG~-Advanced3D Parkinson's stem cell disease models (143,697) - | (143,697) | |
| DepartmentofBiochemistry-Target search mechanisms for bZIP (1) . - . | (1) | |
| -- | ||
| (188,378) | (37,583) | |
| 1,880,504 | 861,920 |
| 2022 | 2021 |
|---|---|
| Number | Number |
| Endowment | Endowment |
|---|---|
| funds | funds |
| general | general |
| 2022 | 2021 |
| £ | £ |
| 3,438,038 | 20,226,663 |
| Investments | |
|---|---|
| £ | |
| Cost or valuation | |
| At 6 April 2021 | 98,759,051 |
| Additions | 2,000,000 |
| Valuation changes | 3,438,038 |
| Disposals | (674,839) |
| At 5 April 2022 | 103,522,250 |
| Carrying amount | |
| At 05 April 2022 | 103,522,250 |
| At 05 April 2021 | 98,759,051 |
| 11 | Financial instruments | 2022 | 2021 |
|---|---|---|---|
| £ | £ | ||
| Carrying amountoffinancial assets | |||
| Instruments measured at fair value through profit or loss | 103,522,250 | 98,759,051 | |
| 12 | Debtors | ||
| 2022 | 2021 | ||
| Amounts falling due within one year: | £ | £ | |
| Other debtors | 387,856 | 373,590 |
| 13 | Creditors: amounts falling due within one year | ||
|---|---|---|---|
| 2022 | 2021 | ||
| £ | £ | ||
| Grants payable | 2,717,021 | 1,924,891 | |
| Accruals | 6,000 | 5,438 | |
| 2,723,021 | 1,930,329 | ||
| 14 | Creditors: amounts falling due after more thanoneyear | ||
| 2022 | 2021 | ||
| £ | £ | ||
| Grants payable | 331,367 | 768,666 |
| No | Grant | 8/fwd2021 N |
ew 2021/22 Ad | justments Pa | id 2020/21 C |
/fwd 2022 |
|---|---|---|---|---|---|---|
| 266 | DepartmentofBiochemistry - Contribution to facility for nanobodies etc. | (50,000) | - | 10 | 49,990 | |
| 277 | DepartmentofExperimental Psychology - retinal imaging for the eye | (30,000) | 30,000 | |||
| 279 | DepartmentofBiochemistry - Confocal microscopy systems | (75,000) | - | 75,000 | ||
| 294 298 |
OUMNH - Summer internship programme DepartmentofChemistry - Chemical Biology Facility |
(48,775) (500,000) |
26,556 | 500,000 | (22,219) | |
| CF 320 CF 332 |
King Edward School - Bursaries and refurbishment OUM NH - public engagement with research - First Animals exhibition |
(400,000) (92,500) |
- - |
100,000 92,500 |
(300,000) | |
| CF 334 CF 335 |
DepartmentofPlant Sciences - Shaking incubator system DepartmentofPlant Sciences - Field emission scanning electron scope |
(16,919) (159,166) |
- | 159,166 | (16,919) | |
| CF 336 | WIMM- Establishing an imaging mass cyometry platform | (50,000) | 50,000 | |||
| CF 338 CF341 CF 342 |
Linacre College - Widening participation scholarships DepartmentofBiochemistry - Specific RNAs DepartmentofChemistry - Inorganic - Developing biocatalysis |
(386,175) (69,763) (72,774) |
1,052 2,808 |
15,000 69,966 |
(370,123) (69,763) |
|
| CF 343 CF 344 CF 345 |
OUMNH a - Project IMAGOS DepartmentofBiochemistry - Expanding access DepartmentofBiochemistry - Histoneingenome stability |
(123,736) (28,160) (32,558) |
1 | 40,962 32,557 |
(82,774) (28,160) |
|
| CF 346 | DepartmentofBiochemistry - Cryo-EM structure determination | (39,839) | 3,581 | 36,258 | ||
| CF 346e | DepartmentofBiochemistry - Cryo-EM structure determination | (10,345) | 10,345 | |||
| CF 349 | DepartmentofBiochemistry - Purchase protein crystal imaging system | (69,194) | 69,194 | |||
| CF351 CF 352 |
DCHI** - Focused ion beam and scanning electron microscope DPAG - Support for year twoofa postdoc |
(366,495) (39,906) |
1 | 39,905 | (366,495) | |
| CF 354 | DepartmentofBiochemistry - Defining the roleofPARPsinthe DNA | (32,252) | 327 | 31,925 | ||
| CF 356 CF 357 CF 358 |
KIR - Establishing Advanced Image Analysis OBGA *** - Plant records management DepartmentofBiochemistry - Support for outreach events |
(79,768) (61,561) (7,360) |
7,360 | (79,768) (61,561) |
||
| CF 359 | DepartmentofBiochemistry-Anultracentrifuge for biochemistry | (40,000) | 40,000 | |||
| CF 360 CF361 CF 362 |
Royal Society - Human genome editing DepartmentofBiochemistry - Support screening microscope DPAGJ3-Advanced30Parkinson's stem cell disease models |
(140,000) (80,000) (143,697) |
1 143,697 |
79,999 | (140,000) |
| 15 | Reconciliationofmovement in grants during the year | (Continued) | |||||
|---|---|---|---|---|---|---|---|
| CF | 363 | DepartmentofBiochemistry - Phosphorylation sites | (30,672) | (30,672) | |||
| CF | 364 | DepartmentofBiochemistry - Regulationofnon-coding RNAs | (47,644) | (47,644) | |||
| CF | 365 | MSDO - Bridging salary scheme | (250,000) | (250,000) | |||
| CF | 366 | HistoryofScience Museum - Collecting COVID | (251,989) | (251,989) | |||
| CF | 367 | EM Facility - Research assistant to support projects | (152,260) | (152,260) | |||
| CF | 368 | DepartmentofBiochemistry - Target search mechanisms for bZIP | (5,890) | 5,889 | |||
| CF | 369 | DepartmentofBiochemistry - Modelling toolkit for glycans | (45,076) | (45,076) | |||
| CF | 370 | DepartmentofBiochemistry - Genotoxic stress on epimutations | (93,474) | (93,474) | |||
| CF | 371 | DepartmentofBiochemistry - Site-specific ADP-ribosylation | (26,522) | (26,522) | |||
| CF | 372 | OUMNH a - Next generationofEPA Internships | (112,969) | (112,969) | |||
| CF | 374 | EM Facility - Newsuiteofelecton microscopes | (500,000) | (500,000) | |||
| (2,693,557) | (2,068,882) | 188,380 | 1,525,671 | (3,048,388) |
| Balance at | Transfers | Revaluations | Balance at | Transfers | Revaluations | Balance at |
|---|---|---|---|---|---|---|
| 6April 2020 | gains and | 6April2021 | gains and | 5April 2022 | ||
| losses | losses | |||||
| £ | £ | £ | £ | £ | £ | £ |
| 75,389,547 | 3,142,841 | 20,226,663 | 98,759,051 | 1,325,161 | 3,438,038 | 103,522,250 |
| 75,389,547 | 3,142,841 | 20,226,663 | 98,759,051 | 1,325,161 | 3,438,038 | 103,522,250 |
| Analysisofnet assets b | etween funds | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Endowment | Total | Unrestricted | Endowment | Total | |
| funds | funds | funds | funds | |||
| 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | |
| £ | £ | £ | £ | £ | £ | |
| Fund balances at 5 | ||||||
| April 2022 are | ||||||
| representedby: | ||||||
| Investments | - | 103,522,250 | 103,522,250 | - | 98,759,051 | 98,,759,051 |
| Current assets/(liabilities) | 2,270,536 | 2,270,536 | 2,096,615 | 2,096,615 | ||
| Long term liabilities | (331,367) | (331,367) | (768,666) | (768,666) | ||
| 1,939,169 | 103,522,250 | 105,461,419 | 1,327,949 | 98,759,051 | 100,087,000 |
| 19 | Cash generated from operations | 2022 | 2021 |
|---|---|---|---|
| £ | £ | ||
| Surplus for the year | 5,374,419 | 22,.873,888 | |
| Adjustments for: | |||
| Investment income recognisedinstatementoffinancial activities | {3,841,435) | (3,527,725) | |
| Gainondisposalofinvestments | (3,438,038) | (20,226,663) | |
| Movements in working capital: | |||
| (Increase)indebtors | (14,266) | (373,590) | |
| Increaseincreditors | 355,393 | 336,280 | |
| -- | |||
| Cash absorbed by operations | {1,563,927) | (917,810) |